Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
   C01 CARDIAC THERAPY
   C02 ANTIHYPERTENSIVES
   C03 DIURETICS
   C04 PERIPHERAL VASODILATORS
   C05 VASOPROTECTIVES
   C07 BETA BLOCKING AGENTS
     C07A BETA BLOCKING AGENTS
       C07AA Beta blocking agents, non-selective
         C07AA01 Alprenolol [DG:DG00303]
         C07AA02 Oxprenolol [DG:DG00304]
         C07AA03 Pindolol
         C07AA05 Propranolol [DG:DG00305]
         C07AA06 Timolol [DG:DG00306]
         C07AA07 Sotalol [DG:DG00307]
         C07AA12 Nadolol
         C07AA14 Mepindolol
         C07AA15 Carteolol [DG:DG00308]
           D07624  Carteolol (INN)
           D00599  Carteolol hydrochloride (JP18/USP) <JP/US>
         C07AA16 Tertatolol [DG:DG00309]
         C07AA17 Bopindolol [DG:DG00310]
         C07AA19 Bupranolol [DG:DG00311]
         C07AA23 Penbutolol [DG:DG00312]
         C07AA27 Cloranolol
       C07AB Beta blocking agents, selective
       C07AG Alpha and beta blocking agents
     C07B BETA BLOCKING AGENTS AND THIAZIDES
     C07C BETA BLOCKING AGENTS AND OTHER DIURETICS
     C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS
     C07E BETA BLOCKING AGENTS AND VASODILATORS
     C07F BETA BLOCKING AGENTS, OTHER COMBINATIONS
   C08 CALCIUM CHANNEL BLOCKERS
   C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C10 LIPID MODIFYING AGENTS
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
   S01 OPHTHALMOLOGICALS
     S01A ANTIINFECTIVES
     S01B ANTIINFLAMMATORY AGENTS
     S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
     S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
       S01EA Sympathomimetics in glaucoma therapy
       S01EB Parasympathomimetics
       S01EC Carbonic anhydrase inhibitors
       S01ED Beta blocking agents
         S01ED01 Timolol [DG:DG00306]
         S01ED02 Betaxolol [DG:DG00315]
         S01ED03 Levobunolol [DG:DG01136]
         S01ED04 Metipranolol [DG:DG01137]
         S01ED05 Carteolol [DG:DG00308]
           D07624  Carteolol (INN)
           D00599  Carteolol hydrochloride (JP18/USP) <JP/US>
         S01ED06 Befunolol [DG:DG01138]
         S01ED51 Timolol, combinations
         S01ED52 Betaxolol, combinations
         S01ED54 Metipranolol, combinations
         S01ED55 Carteolol, combinations
       S01EE Prostaglandin analogues
       S01EX Other antiglaucoma preparations
     S01F MYDRIATICS AND CYCLOPLEGICS
     S01G DECONGESTANTS AND ANTIALLERGICS
     S01H LOCAL ANESTHETICS
     S01J DIAGNOSTIC AGENTS
     S01K SURGICAL AIDS
     S01L OCULAR VASCULAR DISORDER AGENTS
     S01X OTHER OPHTHALMOLOGICALS
   S02 OTOLOGICALS
   S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 16, 2024
According to WHO's ATC 2024

» Japanese version